Starpharma Holdings LimitedASX: SPL

HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model

Apr 26, 2023 at 4:36 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment